Bayer said on October 26, 2026 that China’s National Medical Products Administration (NMPA) has granted marketing ...
AstraZeneca on 25 October 2026 announced positive results from the CLARITY-Gastric01 global Phase III trial, reporting that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results